Correlation Between National Atomic and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both National Atomic and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National Atomic and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National Atomic Co and Sartorius Stedim Biotech, you can compare the effects of market volatilities on National Atomic and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National Atomic with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of National Atomic and Sartorius Stedim.

Diversification Opportunities for National Atomic and Sartorius Stedim

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between National and Sartorius is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding National Atomic Co and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and National Atomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National Atomic Co are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of National Atomic i.e., National Atomic and Sartorius Stedim go up and down completely randomly.

Pair Corralation between National Atomic and Sartorius Stedim

Assuming the 90 days trading horizon National Atomic is expected to generate 5.75 times less return on investment than Sartorius Stedim. But when comparing it to its historical volatility, National Atomic Co is 2.05 times less risky than Sartorius Stedim. It trades about 0.09 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  18,763  in Sartorius Stedim Biotech on November 3, 2024 and sell it today you would earn a total of  3,717  from holding Sartorius Stedim Biotech or generate 19.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

National Atomic Co  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
National Atomic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days National Atomic Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, National Atomic is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Sartorius Stedim unveiled solid returns over the last few months and may actually be approaching a breakup point.

National Atomic and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with National Atomic and Sartorius Stedim

The main advantage of trading using opposite National Atomic and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National Atomic position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind National Atomic Co and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments